Showing 691-700 of 18562 results for "".
From Institutional to Inspiring Healthcare Design
https://reachmd.com/programs/advances-in-long-term-care-medicine/from-institutional-to-inspiring-healthcare-design/5282/Design of healthcare environments is about more than style and aesthetics. A skillfully-designed hospital room can encourage a patient's healing process, overall well-being and better health outcomes, while reducing stress by creating comfortable surroundings. Much like medicine, healthcare design iHarnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
https://reachmd.com/programs/neurofrontiers/harnessing-neuroplasticity-timing-and-intensity-in-post-stroke-aphasia-intervention/32786/For patients who experience aphasia after a stroke, intervention and social support are crucial for recovery. Dr. Kelly Sloane, Assistant Professor of Neurology at the University of Pennsylvania, highlights how timely therapy and strong support systems can help rebuild both language and confidence iUnderstanding the Complex Link Between PIF, Inhaler Choice, and COPD Outcomes
https://reachmd.com/programs/frontlines-copd/understanding-the-complex-link-between-pif-inhaler-choice-and-copd-outcomes/35545/Since suboptimal peak inspiratory flow (PIF) seems to be associated with a higher risk of hospital readmissions and mortality among patients with COPD, it’s now more important than ever to create a clinically relevant definition. Tune in to hear Dr. Jill Ohar discuss this unmet need as well as the iPracticing Physicians Speak Out: CME As We Need It - Part One
https://reachmd.com/programs/lifelong-learning/practicing-physicians-speak-out-cme-as-we-need-it-part-one/6032/When CME content is designed and developed, it is based on educational needs assessments. But needs vary across the spectrum of physicians and types of practices they engage in. What kind of CME is most needed? What are the shortcomings of current delivery modes, as well as CME types? How can theyLife for a Child
https://reachmd.com/programs/clinicians-roundtable/life-for-a-child/1844/Join Dr. Graham Ogle from Sydney, Australia, as he discusses the International Diabetes Federation Life for a Child Program.Investigator Perspectives on Treating Patients in a Ph2 NSCLC Trial
https://reachmd.com/programs/project-oncology/investigator-perspectives-on-treating-patients-in-a-ph2-nsclc-trial/26564/High c-MET protein overexpression is a MET aberration2,3 seen in about 1 in 7 or 14% of patients with EGFR wild-type non-squamous non-small cell lung cancer (NSCLC) tumors. Telisotuzumab vedotin-tllv (Teliso-V) is a first-in-class, c-Met protein-directed antibody-drug conjugate that was studied in tThe Future Is Biochemical
https://modernaesthetics.com/topics/practice-development/the-future-is-biochemical/35417/This frontier is being shaped by a category I call “biochemical cues”: modalities like exosomes, peptides, growth factors, PDRN (polydeoxyribonucleotide), and other regenerative approaches, which tap into the body’s own healing and repair mechanisms to deliver profound results.Analyzing Clinical Trial Data: Part 1
https://reachmd.com/programs/cme/Analyzing-Clinical-Trial-Data-Part-1/35971/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.Analyzing Clinical Trial Data: Part 2
https://reachmd.com/programs/cme/Analyzing-Clinical-Trial-Data-Part-2/35972/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.Epinephrine Evolution: New Developments in Food Allergy Treatment
https://reachmd.com/programs/frontlines-food-allergies/epinephrine-evolution-new-developments-in-food-allergy-treatment/26316/Here’s how nasal and sublingual epinephrine may help address some of the common challenges associated with the traditional injection type.